Work

NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

Year: 2024
Type: editorial
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4402548632
Cites:
Cited by: 3
Related to: 10